Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from FDA

Inside the World of Ambitious Aging

Biohacking promises to make you feel and look decades younger. So what's the catch?

Marie Claire

Biogen Rises As 'Relatively Benign' FDA Documents Suggest An Alzheimer's Approval Is Near

Biogen stock rose Wednesday after the FDA posted documents that suggest the agency will approve Alzheimer's treatment Leqembi.

Investors Business Daily

3 Undervalued Pharma Stocks Worth Buying

With the growing prevalence of chronic diseases, the adoption of advanced digital technologies, and new drug discoveries, the pharmaceutical industry is set to witness significant growth this year and beyond. Thus, it could be wise to invest in quality pharma stocks Ipsen (IPSEY), Supernus (SUPN), and Kamada (KMDA), which are…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

The anti-vaxxer threat keeps spreading

With vaccines on the horizon, RSV could finally be preventable. But anti-vax misinfo could get in the way

Salon

AI in medicine needs to be carefully deployed to counter bias – and not entrench it

Powerful new artificial intelligence tools can perpetuate long-standing racial inequities if they are not designed very carefully. Researchers and regulators are taking note, but perils are vast.

WEKU

This Herbal Supplement is Hailed as "Nature's Ozempic," but How Safe is It?

TikTokers are using the dietary supplement berberine, calling it "nature's Ozempic" as a weight-loss drug that's cheaper and easier to attain.

Inverse

Elon Musk's Neuralink Brain Implant Approved for Human Trials in the US — Is It Safe?

The implant sends their brain signals via Bluetooth to a computer, which then translates their intended action into tasks on a computer.

Inverse

Read news from The Economist, FT, and more,
with one subscription

Brain implants: The reality behind Elon Musk’s sci-fi dreams of mind control

Elon Musk’s Neuralink has brought a lot of attention to the world of brain-computer interfaces but whether we need implants in our heads is debatable.

Evening Standard

The FDA Just Approved a Game-Changing OTC Birth Control Pill — Should You Switch to It?

The Opill contains a low dose of progestin at 0.075 milligrams per pill, and has to be taken at the same time every day.

Inverse

Next COVID vax might drop OG strain

Scientists debate the benefits of bivalent and monovalent shots

Salon

Elon Musk’s brain implant company is approved for human testing. How alarmed should we be?

The billionaire’s record has raised concerns over Neuralink’s ability to responsibly oversee the development of such an invasive device

The Guardian - US

Elon Musk's Neuralink 'brain chips' cleared for 1st in-human trials

Brain implants developed by Elon Musk's company Neuralink have been approved for human testing. The safety of the devices previously came under scrutiny following reports of "botched surgeries" in animal test subjects.

LiveScience

Health advocates urge US regulators to ban common food coloring additive

Titanium dioxide, found in candy, meat substitutes and packaged cookies, has been linked to a range of serious health issues

The Guardian - US

Watch out for Ozempic copycats containing unauthorized active ingredients, FDA warns

Some compounding pharmacies are using unauthorized active ingredients to make copycat versions of Ozempic and Wegovy.

LiveScience

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

FDA warns against using off-brand versions of Ozempic, Wegovy for weight loss

FDA has warned consumers against using ‘compounded’ versions of semaglutide, the key ingredient found in Ozempic and Wegovy

LiveScience

What is SPF? A guide to understanding sunscreen labels

Confused by sunscreen terminology? Here is everything you need to know to understand sunscreen labels.

Investors Business Daily

Biohaven, A Top 2% Stock, Exits 'Stealth Mode' And Hits A Record High

Biohaven is coming "out of stealth mode," an analyst said Thursday as BHVN stock climbed for a fourth consecutive day.

Woman & Home

What is Ozempic face? Plus, why it really happens and how to fix it

Ozempic face is one of the most famous reported side effects of the injectable. Here, three doctors reveal what you need to know about it

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

FDA warns consumers not to use off-brand versions of Ozempic, Wegovy

The U.S. Food and Drug Administration is warning consumers not to use versions of the popular weight-loss drug used in Ozempic and Wegovy and sold online because they might not contain the same ingredients as prescription products and may not be safe or effective

The Conversation

Drugs that melt away pounds still present more questions than answers, but Ozempic, Wegovy and Mounjaro could be key tools in reducing the obesity epidemic

In the past five years, several new drugs have been brought to market that could lead to a profound, if not revolutionary, change in how health care providers – and the public – view weight loss.

Businessweek

Opioid Crisis Spurred by Animal Sedative’s Stealth Emergence

Officials are trying to clamp down on the illicit supply of xylazine, a veterinary drug sold online.

The Hindu

What were FDA’s concerns over Elon Musk’s Neuralink chip?

Neuralink is making a Class III medical device known as a brain-computer interface. The device connects the brain to an external computer via a Bluetooth signal, enabling continuous communication back and forth. It could revolutionise treatment for conditions such as Parkinson’s disease, epilepsy, and spinal cord injuries.

Salon

FDA greenlights Musk's Neuralink trials

Musk has made many radical claims regarding his future vision for the technology. What comes after FDA approval?

Reason

How To Restrain the A.I. Regulators

A more flexible model of oversight avoids hyper-cautious top-down regulation and enables swifter access to the substantial benefits of safe A.I.

Birmingham Post

Manus Neurodynamica scoops £2.6m to support marketing of its brain disorder tech

The firm has developed a tool that can help faster and simpler diagnosis of diseases such as Parkinson's

1 … 68 69 70 71

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.